Título:
|
Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase
|
Autores:
|
Montenegro-Garreaud, Ximena ;
Miranda, Roberto N. ;
Reynolds, Alexandra ;
Tang, Guilin ;
Wang, Sa A. ;
Yabe, Mariko ;
Wang, Wei ;
Fang, Lianghua ;
Bueso-Ramos, Carlos E. ;
Lin, Pei ;
Medeiros, L. Jeffrey ;
Lu, Xinyan
|
Tipo de documento:
|
texto impreso
|
Editorial:
|
Elsevier, 2019-01-25T15:28:06Z
|
Nota general:
|
info:eu-repo/semantics/restrictedAccess
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
|
Idiomas:
|
Inglés
|
Palabras clave:
|
Editados por otras instituciones
,
Artículos
,
Artículos en revistas indizadas
|
Resumen:
|
Rearrangements of FGFR1 result in the 8p11 myeloproliferative syndrome, a group of rare diseases that features a myeloproliferative neoplasm (MPN) that commonly progresses to lymphoblastic leukemia/lymphoma or acute myeloid leukemia. The most common partner of FGFR1 is ZMYM2, and patients with the ZMYM2-FGFR1 fusion often present with MPN and T-lymphoblastic lymphoma. There are 14 other partners that can fuse with FGFR1, and of interest is the BCR-FGFR1 fusion that results from t(8;22)(p11.2;q11.2). Patients with t(8;22) often show leukocytosis and present with an MPN resembling chronic myeloid leukemia or very rarely, with
|
En línea:
|
http://doi.org/10.1016/j.humpath.2017.05.008
|